How to Sell a Behavioral Health Practice

Demand for behavioral health services has outrun supply for a decade, and capital has followed. That has created a real buyer market for practices that were built by one or two clinicians and never intended to be sold. If you own an outpatient therapy group, an intensive outpatient or partial hospitalisation program, a substance use treatment provider, or an ABA agency, this guide covers how buyers value what you built, the regulatory mechanics that decide the timeline, and the specific things that get a deal repriced late.

Payer contracts are the asset

In most behavioral health transactions the payer contracts are worth more than the equipment, the lease, and the brand combined. Buyers look at which commercial plans you are in network with, what your contracted rates are relative to the regional norm, how much of your revenue sits with each payer, and how long those agreements have run. A practice with above-market rates on a multi-year commercial contract is genuinely scarce. A practice with 60 percent of revenue from one Medicaid managed care plan is a concentration risk that will be structured around rather than paid for.

• Rate schedule by payer and CPT code, with the effective date of each contract.
• Revenue mix across commercial, Medicaid, Medicare, and self-pay, with the trend over three years.
• Denial and authorisation rates by payer, and days in accounts receivable.
• Whether contracts are held by the entity being sold or by an individual clinician, because the second case does not transfer.

Change of ownership is the timeline, not the diligence

Behavioral health deals are paced by regulators, not by lawyers. A change of ownership can require notice or reapplication for state behavioral health licences, Medicaid provider enrolment, DEA registrations where controlled substances are involved, and payer recredentialing. Some of those take weeks and some take six months, and a few states treat a change of control as a new licence application entirely. Buyers price this, and structures reflect it: expect closing conditions tied to licensure, and expect part of the purchase price to be held in escrow until enrolments are confirmed. Understanding your own change-of-ownership path before you go to market is the single best thing you can do for deal certainty.

Accreditation and level of care

Accreditation from CARF or the Joint Commission is not required everywhere, but it changes the buyer pool. Accredited providers can contract with payers that will not otherwise contract, can operate higher levels of care, and carry a documented quality system that survives a change of owner. Level of care matters for the same reason. Standard outpatient therapy is the most commoditised and the least capital intensive. Intensive outpatient, partial hospitalisation, residential, and medication-assisted treatment carry higher reimbursement, higher regulatory burden, and materially higher multiples, because the barriers that make them hard to run are the same barriers that make them hard to replicate.

Clinician supply is the operating risk buyers underwrite

A behavioral health practice is a group of licensed people and a schedule. Buyers therefore spend more diligence time on staffing than on anything except payer mix. They want to see clinician tenure, the ratio of employed clinicians to contractors, caseload and utilisation per clinician, supervision structure for pre-licensed staff, and how many of your clinicians have enforceable, reasonable restrictive covenants. A practice where half the clinical staff are 1099 contractors with no restrictive covenant and no non-solicit is a practice a buyer can lose in ninety days, and it is priced that way.

• Employed versus contracted clinicians, and whether the classification would survive scrutiny.
• Average clinician tenure and rolling twelve-month turnover.
• Utilisation: scheduled hours against billable hours, and the no-show rate.
• Supervision capacity for associate-level clinicians, which is both a growth lever and a bottleneck.

Owner dependence in a clinical business

If you are the highest-billing clinician, the clinical director, and the person every referral source knows, a buyer is not acquiring a business, they are acquiring your calendar. The fix is structural: hire or promote a clinical director who is not you, move referral relationships onto the practice rather than your name, and be able to show at least a couple of quarters where your personal production was a small fraction of total revenue. This is the difference between a practice valued on SDE and one valued on EBITDA, and it is usually the single largest lever an owner controls. The entry on owner dependence covers how buyers quantify it.

Compliance history, records, and the corporate practice question

Diligence will cover documentation quality, medical necessity support, billing accuracy, and any history of payer audits, recoupments, or corrective action plans. Providers treating substance use disorder carry additional federal confidentiality obligations for patient records that shape how information can be shared in a data room. Separately, many states restrict who may own a clinical entity, which is why buyers frequently use a management services organisation structure: the clinical entity stays owned by licensed professionals and the MSO acquires the non-clinical assets under a long-term services agreement. If a buyer proposes that structure, it is normal in this sector rather than a warning sign, but it needs healthcare counsel who practises in your state.

Who buys behavioral health practices

Private-equity-backed behavioral platforms are the most active acquirers and are building regional density in outpatient therapy, ABA, and substance use treatment; they pay EBITDA multiples and expect a management layer. Health systems and payer-owned provider arms buy for network adequacy and referral capture, and they can move slowly but pay for scale and quality metrics. Larger regional providers buy for geography and clinician supply. Finally, associate or management buyouts are common in smaller practices and usually involve seller financing. Owners who want to understand which of these is actually shopping for a practice like theirs can start with a private buyer-fit check.

What to do in the eighteen months before a sale

• Move every payer contract, licence, and lease into the entity that will be sold.
• Convert key clinicians to employment with reasonable non-solicit terms, and fix any classification exposure.
• Build a monthly dashboard: visits, utilisation, payer mix, denials, and days in AR.
• Reduce your own clinical production deliberately and promote a clinical director.
• Get a compliance review before a buyer does one, and remediate rather than disclose late.